Myelodysplastic syndromes (MDS) cause atypical bone marrow cells and low blood counts. This can lead to fatigue, shortness of breath, infections, bruising, and bleeding. Myelodysplastic syndromes (MDS ...

Key considerations for appropriate MDS treatment selection are discussed by expert panelists. Ryan Haumschild, PharmD, MS, MBA: Dr Weaver, I’m curious about your thoughts. I’m hearing that there are ...

Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...

Infection is the leading cause of death in LR-MDS patients, responsible for 24.6% of deaths within a year of diagnosis. Key risk factors for infection include intermediate or higher IPSS-R risk, ...

Dr. Shah was compensated by BMS for his participation. Photo Credit: Shutterstock As you age, feeling tired or short of breath may be dismissed as a part of getting older, but it’s important to talk ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, researchers urged. Patients with myelodysplastic syndromes (MDS) may ...

Reblozyl for anemia in patients with an MDS subset demonstrated positive effects, compared with previous treatments, according to an MDS expert. Treatment with Reblozyl (luspatercept-aamt) was ...